Patents by Inventor Hannah Bulovsky

Hannah Bulovsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of a somatostatin modulator
    Patent number: 11957674
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: April 16, 2024
    Assignee: CRINETICS PHARMACEUTICALS, INC.
    Inventors: Gerald Burke, Ian Yates, Hannah Bulovsky, Kyle Kyburz, Clayton Tyler
  • FORMULATIONS OF A SOMATOSTATIN MODULATOR
    Publication number: 20220143007
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Application
    Filed: January 25, 2022
    Publication date: May 12, 2022
    Inventors: Gerald BURKE, Ian YATES, Hannah BULOVSKY, Kyle KYBURZ, Clayton TYLER
  • FORMULATIONS OF A SOMATOSTATIN MODULATOR
    Publication number: 20220071986
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Application
    Filed: September 7, 2021
    Publication date: March 10, 2022
    Inventors: Gerald BURKE, Ian YATES, Hannah BULOVSKY, Kyle KYBURZ, Clayton TYLER
  • Formulations of a somatostatin modulator
    Patent number: 11266641
    Abstract: Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: March 8, 2022
    Assignee: CRINETICS PHARMACEUTICALS, INC.
    Inventors: Gerald Burke, Ian Yates, Hannah Bulovsky, Kyle Kyburz, Clayton Tyler